Cargando…

Implementation and Rationale for a Unified Clinical and Imaging Protocol for Evaluation and Treatment of Moyamoya Angiopathy: A Single Institutional Experience

Moyamoya disease (MMD) is a complex and incompletely-understood cerebrovascular pathological entity that requires thorough clinical and imaging evaluation. Moyamoya is rare, thereby making the establishment of an effective, thorough and interdisciplinary patient evaluation protocol challenging, even...

Descripción completa

Detalles Bibliográficos
Autores principales: Larson, Anthony S., Lehman, Vance T., Savastano, Luis E., Lanzino, Giuseppe, Campeau, Norbert G., Welker, Kirk M., Klaas, James P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165224/
https://www.ncbi.nlm.nih.gov/pubmed/34079514
http://dx.doi.org/10.3389/fneur.2021.662393
_version_ 1783701272534188032
author Larson, Anthony S.
Lehman, Vance T.
Savastano, Luis E.
Lanzino, Giuseppe
Campeau, Norbert G.
Welker, Kirk M.
Klaas, James P.
author_facet Larson, Anthony S.
Lehman, Vance T.
Savastano, Luis E.
Lanzino, Giuseppe
Campeau, Norbert G.
Welker, Kirk M.
Klaas, James P.
author_sort Larson, Anthony S.
collection PubMed
description Moyamoya disease (MMD) is a complex and incompletely-understood cerebrovascular pathological entity that requires thorough clinical and imaging evaluation. Moyamoya is rare, thereby making the establishment of an effective, thorough and interdisciplinary patient evaluation protocol challenging, even within specialized referral centers. Nevertheless, implementation of such a protocol is crucial in order to provide the best possible evaluation and treatment for MMD patients. Here, we describe our institution's implementation of, rationale for, and experience with a comprehensive multidisciplinary collaboration and evaluation strategy for adult patients with moyamoya. This evaluation course consists of, first of all, a thorough clinical and laboratory evaluation with a vascular neurologist. This is followed by a comprehensive imaging assessment which evaluates angiographic and parenchymal features, in addition to cerebrovascular functionality. Finally, appropriate referrals are made to consulting services as indicated, which includes vascular neurosurgery. These steps are described in detail herein.
format Online
Article
Text
id pubmed-8165224
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81652242021-06-01 Implementation and Rationale for a Unified Clinical and Imaging Protocol for Evaluation and Treatment of Moyamoya Angiopathy: A Single Institutional Experience Larson, Anthony S. Lehman, Vance T. Savastano, Luis E. Lanzino, Giuseppe Campeau, Norbert G. Welker, Kirk M. Klaas, James P. Front Neurol Neurology Moyamoya disease (MMD) is a complex and incompletely-understood cerebrovascular pathological entity that requires thorough clinical and imaging evaluation. Moyamoya is rare, thereby making the establishment of an effective, thorough and interdisciplinary patient evaluation protocol challenging, even within specialized referral centers. Nevertheless, implementation of such a protocol is crucial in order to provide the best possible evaluation and treatment for MMD patients. Here, we describe our institution's implementation of, rationale for, and experience with a comprehensive multidisciplinary collaboration and evaluation strategy for adult patients with moyamoya. This evaluation course consists of, first of all, a thorough clinical and laboratory evaluation with a vascular neurologist. This is followed by a comprehensive imaging assessment which evaluates angiographic and parenchymal features, in addition to cerebrovascular functionality. Finally, appropriate referrals are made to consulting services as indicated, which includes vascular neurosurgery. These steps are described in detail herein. Frontiers Media S.A. 2021-05-17 /pmc/articles/PMC8165224/ /pubmed/34079514 http://dx.doi.org/10.3389/fneur.2021.662393 Text en Copyright © 2021 Larson, Lehman, Savastano, Lanzino, Campeau, Welker and Klaas. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Larson, Anthony S.
Lehman, Vance T.
Savastano, Luis E.
Lanzino, Giuseppe
Campeau, Norbert G.
Welker, Kirk M.
Klaas, James P.
Implementation and Rationale for a Unified Clinical and Imaging Protocol for Evaluation and Treatment of Moyamoya Angiopathy: A Single Institutional Experience
title Implementation and Rationale for a Unified Clinical and Imaging Protocol for Evaluation and Treatment of Moyamoya Angiopathy: A Single Institutional Experience
title_full Implementation and Rationale for a Unified Clinical and Imaging Protocol for Evaluation and Treatment of Moyamoya Angiopathy: A Single Institutional Experience
title_fullStr Implementation and Rationale for a Unified Clinical and Imaging Protocol for Evaluation and Treatment of Moyamoya Angiopathy: A Single Institutional Experience
title_full_unstemmed Implementation and Rationale for a Unified Clinical and Imaging Protocol for Evaluation and Treatment of Moyamoya Angiopathy: A Single Institutional Experience
title_short Implementation and Rationale for a Unified Clinical and Imaging Protocol for Evaluation and Treatment of Moyamoya Angiopathy: A Single Institutional Experience
title_sort implementation and rationale for a unified clinical and imaging protocol for evaluation and treatment of moyamoya angiopathy: a single institutional experience
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165224/
https://www.ncbi.nlm.nih.gov/pubmed/34079514
http://dx.doi.org/10.3389/fneur.2021.662393
work_keys_str_mv AT larsonanthonys implementationandrationaleforaunifiedclinicalandimagingprotocolforevaluationandtreatmentofmoyamoyaangiopathyasingleinstitutionalexperience
AT lehmanvancet implementationandrationaleforaunifiedclinicalandimagingprotocolforevaluationandtreatmentofmoyamoyaangiopathyasingleinstitutionalexperience
AT savastanoluise implementationandrationaleforaunifiedclinicalandimagingprotocolforevaluationandtreatmentofmoyamoyaangiopathyasingleinstitutionalexperience
AT lanzinogiuseppe implementationandrationaleforaunifiedclinicalandimagingprotocolforevaluationandtreatmentofmoyamoyaangiopathyasingleinstitutionalexperience
AT campeaunorbertg implementationandrationaleforaunifiedclinicalandimagingprotocolforevaluationandtreatmentofmoyamoyaangiopathyasingleinstitutionalexperience
AT welkerkirkm implementationandrationaleforaunifiedclinicalandimagingprotocolforevaluationandtreatmentofmoyamoyaangiopathyasingleinstitutionalexperience
AT klaasjamesp implementationandrationaleforaunifiedclinicalandimagingprotocolforevaluationandtreatmentofmoyamoyaangiopathyasingleinstitutionalexperience